Biochemistry

Glycolysis for NEET PG: The Three Enzymes That Actually Decide the Answer

Reflex · 16 Sept 2026 · 12 min read

Last updated: 18 Sept 2026

On this page

Glycolysis questions on NEET PG rarely test the ten steps as a memorization exercise — they test whether you know the three irreversible, hormonally-regulated enzymes, where the pathway's NADH comes from, and what happens once it branches at pyruvate. Those specific landmarks are where almost every real question sits.

The Two Phases: Investment, Then Payoff

Glycolysis splits cleanly into an investment phase and a payoff phase. The investment phase consumes 2 ATP to convert one glucose molecule into two molecules of glyceraldehyde-3-phosphate, destabilising glucose enough for the rest of the pathway to proceed. The payoff phase then generates 4 ATP and 2 NADH from those two three-carbon fragments, giving a net yield of 2 ATP and 2 NADH per glucose molecule overall — the factor-of-two arithmetic here is a genuinely common source of careless errors, since every payoff-phase step happens twice per original glucose molecule.

The Ten Steps, at a Glance

Step Enzyme Type
1 Hexokinase / Glucokinase Irreversible
2 Phosphoglucose isomerase Reversible
3 Phosphofructokinase-1 Irreversible
4 Aldolase Reversible
5 Triose phosphate isomerase Reversible
6 Glyceraldehyde-3-phosphate dehydrogenase Reversible
7 Phosphoglycerate kinase Reversible
8 Phosphoglycerate mutase Reversible
9 Enolase Reversible
10 Pyruvate kinase Irreversible

The Three Rate-Limiting Enzymes

Hexokinase (or glucokinase in the liver) catalyses the first committed step, phosphorylating glucose to glucose-6-phosphate and trapping it inside the cell. Hexokinase has a low Km and is inhibited by its own product; glucokinase, the liver-specific isoform, has a much higher Km, isn't product-inhibited, and only activates once blood glucose is genuinely elevated — which is exactly why the liver holds off taking up large amounts of glucose until after a meal, rather than competing with peripheral tissues when glucose is scarce.

Phosphofructokinase-1 (PFK-1) is the pathway's actual control point, and the enzyme NEET PG questions return to most often. It's allosterically activated by AMP and fructose-2,6-bisphosphate, and inhibited by ATP and citrate — a direct readout of the cell's energy and biosynthetic status. Fructose-2,6-bisphosphate itself sits under hormonal control: insulin raises it, activating PFK-1 and pushing glycolytic flux forward; glucagon lowers it, easing off PFK-1 and favouring gluconeogenesis instead. This is the actual molecular link between a post-meal insulin spike and increased cellular glucose breakdown.

Pyruvate kinase catalyses the final, ATP-generating step, converting phosphoenolpyruvate to pyruvate. It's activated by fructose-1,6-bisphosphate (feed-forward activation from an upstream intermediate) and inhibited by ATP and alanine — the alanine inhibition specifically ties glycolysis to the glucose-alanine cycle between muscle and liver, a connection worth remembering since it links two topics that otherwise feel unrelated.

Where the NADH Comes From

Glyceraldehyde-3-phosphate dehydrogenase is the single NADH-generating step, oxidising glyceraldehyde-3-phosphate while reducing NAD+ to NADH. Since this happens twice per glucose molecule, the pathway yields 2 NADH total. Regenerating that NAD+ supply is the entire reason fermentation exists under anaerobic conditions — without it, this one step stalls and takes the rest of glycolysis down with it, regardless of how much ATP is still available elsewhere in the cell.

What Happens to Pyruvate Next

Glycolysis itself ends at pyruvate, and where pyruvate goes depends entirely on oxygen availability — a branch point NEET PG tests as often as the pathway itself. Under aerobic conditions, pyruvate enters mitochondria and is converted to acetyl-CoA by pyruvate dehydrogenase, feeding the citric acid cycle and oxidative phosphorylation, extracting far more ATP per glucose than glycolysis alone can. Under anaerobic conditions, pyruvate is reduced to lactate instead, purely to regenerate the NAD+ glycolysis needs to keep running — the ATP yield stays capped at glycolysis's own 2 per glucose, since the electron transport chain never gets involved.

Red blood cells, having no mitochondria at all, depend on this anaerobic route as their only source of ATP. Skeletal muscle does the same under intense exertion when oxygen delivery can't keep pace, and the resulting lactate isn't waste — it's shuttled to the liver via the Cori cycle and converted back to glucose through gluconeogenesis, closing the loop rather than dead-ending it.

A genuinely interesting exception worth knowing: many cancer cells preferentially ferment glucose to lactate even with oxygen fully available, a pattern called the Warburg effect. The leading explanation is that rapidly dividing cells need glycolytic intermediates as raw material for nucleotides, amino acids, and lipids more than they need the higher ATP yield aerobic metabolism would otherwise provide — and this metabolic preference is distinct enough to be exploited diagnostically in PET imaging of tumours.

Clinical Correlation: Pyruvate Kinase Deficiency

Pyruvate kinase deficiency is the classic clinical link for this pathway, tested specifically through its effect on red blood cells. Since mature red cells depend entirely on glycolysis for ATP, a deficiency in the pathway's final enzyme leaves them without enough energy to maintain membrane integrity and their normal biconcave shape, producing hemolytic anemia. It's a clean example of a purely biochemical pathway having a direct, testable clinical consequence when one specific enzyme fails.

How Glycolysis Differs by Tissue

The pathway's steps are identical everywhere, but which isoforms are expressed and how tightly the pathway is regulated varies meaningfully by tissue, and this variation is itself a testable layer on top of the core mechanism. The brain relies on glucose as its dominant fuel and runs glycolysis at a steady, largely unregulated pace to meet constant energy demand, with minimal hormonal override compared to other tissues — brain glucose uptake through GLUT3 doesn't require insulin, unlike muscle and fat.

Skeletal muscle, by contrast, ramps glycolysis up dramatically during exercise, driven by rising AMP and falling ATP as contraction consumes energy — the same PFK-1 allosteric logic already covered, just triggered by local energy demand rather than a hormonal signal. Red blood cells run glycolysis as their sole ATP source with no capacity to switch to oxidative metabolism at all, since they have no mitochondria, making them uniquely dependent on this one pathway functioning correctly.

The liver is the clear outlier: rather than running glycolysis to meet its own energy needs primarily, it uses glucokinase's high-Km behaviour to only engage glycolysis heavily when blood glucose is already high, storing the resulting carbon skeletons as glycogen or fat rather than burning them immediately — the liver is, in this sense, managing glucose on behalf of the whole body rather than purely for itself.

Why This Pathway Gets Tested So Consistently

Glycolysis sits at a genuine crossroads of NEET PG's major themes: it connects to endocrinology through insulin and glucagon signalling, to hematology through pyruvate kinase deficiency and red cell metabolism, to oncology through the Warburg effect, and to exercise physiology through the aerobic-anaerobic branch point. A single well-understood pathway is doing the work of several separate topics, which is exactly why it keeps reappearing across different sections of the exam rather than staying confined to one.

Reading a glycolysis vignette efficiently means identifying which layer is actually being tested: the core ten-step mechanism, the hormonal regulation overlaying it, the tissue-specific variation on top of that, or a downstream clinical consequence of one enzyme failing. Most questions sit clearly in one of these four layers rather than blending them together, and recognising which specific layer is in play narrows the answer considerably before working through the underlying biochemistry itself, rather than trying to hold all four layers in mind at once.

For the same pathway-first approach applied to a related topic, see our guide to Krebs cycle mnemonic, and for how much of the paper Biochemistry carries overall, our subject-wise weightage breakdown.

Practise this on Reflex

Turn what you just read into recall with 14 years of tagged PYQs.

FAQ

Frequently asked questions

The questions aspirants ask most about this topic.

Hexokinase (or glucokinase in the liver), phosphofructokinase-1, and pyruvate kinase. All three catalyse irreversible reactions and are the pathway's main regulatory points.

It's allosterically activated by AMP and fructose-2,6-bisphosphate when energy is needed, and inhibited by ATP and citrate when energy is abundant.

Hexokinase has a low Km and is inhibited by its own product. Glucokinase, found in the liver, has a much higher Km and only activates when blood glucose is genuinely high.

Insulin raises fructose-2,6-bisphosphate, which allosterically activates PFK-1, pushing glycolytic flux forward.

Under aerobic conditions, pyruvate becomes acetyl-CoA, feeding the citric acid cycle. Under anaerobic conditions, it's reduced to lactate instead, regenerating NAD+.

The brain uses GLUT3, an insulin-independent glucose transporter, reflecting its constant, high-priority energy demand.

A pattern where many cancer cells preferentially ferment glucose to lactate even with oxygen available, likely because rapidly dividing cells need glycolytic intermediates as biosynthetic building blocks.

Stay ahead in your preparation

Get expert tips, exam updates, and high-yield insights delivered straight to your inbox.

No spam. Unsubscribe anytime.

More in Subject Notes

View all →